Opportunity & pathway assessment
Clarify the product, intended use, existing approvals, evidence status and commercial objective before selecting a China route.
Global devices into China
CUMEDI provides China medical device market-entry support for international manufacturers by organizing regulatory, partner and commercial workstreams around one product and business case.
Clarify the product, intended use, existing approvals, evidence status and commercial objective before selecting a China route.
Map the likely classification and registration questions, then coordinate with qualified regulatory specialists for formal advice and submissions.
Identify and screen potential import, distribution, clinical, service or commercial partners against the agreed market role.
Coordinate localized materials, partner handoffs, commercial milestones and the evidence needed for the next investment decision.
Important boundary
CUMEDIStructures the project, gathers information, coordinates local specialists and supports partner development.
Qualified specialistsProvide formal classification, registration, testing, clinical and legal advice where required.
Device companyOwns product evidence, applicant decisions, claims and final commercial authorization.
First discussion
Regulatory reference reviewed August 2026: China’s current registration provisions state that imported Class II and Class III devices are handled through registration, while imported Class I devices are filed. Product-specific classification and requirements must be confirmed.
Read the NMPA provisionsChina market entry · 9 min
China partners · 8 min
China regulation · 8 min
China entry assessment